Yazar "Hacievliyagil S.S." seçeneğine göre listele
Listeleniyor 1 - 5 / 5
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Acute oxygen treatment(2004) Kizkin O.; Hacievliyagil S.S.; Günen H.Oxygen treatment is commonly used in clinical practice. Although this treatment was taught during medical education under different titles, it is observed that doctors do not administer oxygen treatment in adequate periods and doses. The possible cause of this may be that oxygen is not considered as a drug. The results of inadequate dose and insufficient monitoring in oxygen treatment would be serious. On the other hand, failure to correct hypoxaemia fearing from hypoventilation and carbon dioxide retention is not acceptable. For a safe oxygen treatment, doctor must know its indications, oxygen delivery systems, flow rates and monitoring. The aim of this review is to refresh our knowledge about when, how and how much to start oxygen treatment and how to monitor it.Öğe The cost of treatment in new case and multidrug resistant case in pulmonary tuberculosis(2003) Kizkin O.; Hacievliyagil S.S.; Türker G.; Günen H.The treatment of multidrug-resistant pulmonary tuberculosis (MDR-Tbc) is quite difficult, and the disease has high morbidity and mortality rates. This study was designed to compare the costs of treatment in new tuberculosis (new-Tbc) cases and MDR-Tbc cases. Data base of the study was composed of the data from therapy principles of new-Tbc cases and MDR-Tbc, and official directives and price lists of Turkish Pharmacology Society in 2001 fiscal year regulating treatment costs. For new-Tbc cases, the treatment cost included expanses for 20 days of hospitalisation, one month work loss and six months drug supply and laboratory costs; for MDR-Tbc cases, it was comprised by expenses for seven months hospitalisation in average, 12 months work loss, 24 months drug supply and laboratory costs, and probable surgical interventions and post-operative intensive care. The service of hospital stuff and medical equipment provided was disregarded. The cost analyses was calculated as charge price of American dollars ($) dated 14.09.2001. It was found that the cost of therapy for new-Tbc cases and MDR-Tbc cases were 1134.89 $ and 17529.15 $, respectively. In MDR-Tbc cases, the costs of hospitalisation, work loss, drug therapy and laboratory procedures were 10.5, 12, 98.7 and 5.3 times higher respectively, when compared with those of new-Tbc. The cost of thoracotomy for one patient including the cost for 10 days period of post-operative care in intensive care unit was 391.93 $. The treatment of MDR-Tbc has a high cost, and 16 new-Tbc cases can be treated with the same cost in our country. In conclusion, we think that successful treatment strategies for both new-Tbc cases and MDR-Tbc cases will lower the cost of tuberculosis treatment.Öğe EVALUATION OF THE ASSOCIATION BETWEEN PROPER INHALER TECHNIQUE AND ANXIETY IN CHEST DISEASES OUTPATIENT CLINIC PATIENTS DURING COVID-19 PANDEMIC: A PROSPECTIVE CROSS-SECTIONAL STUDY(University of Ankara, 2022) Durmuş M.; Gök S.; Bahçecioğlu Ö.F.; Gün Z.Ü.; Hacievliyagil S.S.Objective: In this study, we aimed to investigate the association between inhaler use skills and general anxiety or coronavirus anxiety scores in patients with respiratory diseases. Material and Method: Inhaler techniques of 70 asthma and chronic obstructive pulmonary disease (COPD) patients were evaluated by three clinical pharmacists. A pulmonologist assessed the patients' anxiety scores using the Hamilton Anxiety Rating Scale (HAM-A) and Coronavirus Anxiety Scale (CAS). We used IBM SPSS 25.0 as a software program for related statistical analysis Result and Discussion: Proper inhaler technique wasn’t found to be associated with CAS score, age, comorbidity, inhaler type. HAM-A stage (p=0.096) and educational status (p=0.074) were not found as statistically significant in affecting the proper inhaler technique. A weak correlation was found between age and CAS score (r=-0.278, p=0.02). Asthma patients have a higher rate of coronavirus anxiety than COPD patients (p=0.036). Female patients had higher HAM-A (p=0,037) and CAS scores (p=0,002) than male patients. There was a moderate correlation between HAM-A and CAS scores (r=0.407, p<0.001). The correlation between HAM-A and inhaler use skills scores were not found in statistical significance (r=-0.208, p=0.083). In conclusion, increase of CAS score wasn’t found to be associated with proper inhaler technique. HAM-A score was found to affect proper inhaler technique negatively, but these results are not significant. © 2022 Authors. All rights reserved.Öğe Prognostic role of simplified pulmonary embolism severity index and the European society of cardiology prognostic model in short- and long-term risk stratification in pulmonary embolism(Professional Medical Publications, 2014) Kilic T.; Gunen H.; Gulbas G.; Hacievliyagil S.S.; Ozer A.Objectives: Hemodynamic status, cardiac enzymes, and imaging-based risk stratification are frequently used to evaluate a pulmonary embolism (PE). This study investigated the prognostic role of a simplified Pulmonary Embolism Severity Index (sPESI) score and the European Society of Cardiology (ESC) model. Methods: The study included 50 patients from the emergency and pulmonology department of one medical center between October 2005 and June 2006. The ability of the sPESI and ESC model to predict shortterm (in-hospital) and long-term (6-month and 6-year) overall mortality was assessed, in addition to the accurancy of the sPESI and ESC model in predicting short-term adverse events, such as cardiopulmonary resuscitation, or major bleeding. Results: Of the 50 patients, the in-hospital and 6-year mortality rates were 14% and 46%, respectively. Fifteen (30%) of these experienced adverse events during hospitalization. Importantly, patients classified as low-risk according to the sPESI had no short-term adverse events as opposed to 4.8% in the ESC low-risk group. They also had no in-hospital, 6-month, or 6-year mortality compared to 4.8%, %14.3, and %23.8, respectively, in the ESC low-risk group. Conclusions: The sPESI predicted short-term and long-term survival. The exclusion of short-term adverse events does not appear to require imaging and laboratory testing. © 2014 Professional Medical Publications. All right reserved.Öğe Smoking status of pulmonologists who are members of Turkish thoracic society and factors related to their being a smoker(Turkiye Klinikleri, 2013) Pazarli Bostan P.; Aytemur Z.A.; Hacievliyagil S.S.; Öztuna F.; Örsel O.; Kiran S.Objective: If smoking habit among physicians in a country is common as it is in the general population, it is a particular problem for national tobacco control studies. The study aimed to investigate the smoking status of pulmonologists who are members of the Turkish Thoracic Society (TTS), and factors related with being a smoker. Material and Methods: Web-questionnaires were e-mailed to members of TTS by the TTS secretary from June 2010-February 2011. Only pulmonologists were included in the study. To analyse possible predictors of smoking smokers were categorized as ever smokers and never smokers. Possible predictors were sex, being graduated before/after 2004, urban/suburban working place, being academician or not, having education on smoking cessation help, experienced in smoking cessation outpatient clinic or not. Results: Web questionnaires of 699 pulmonologists were reviewed. Of the participants, 65.2% were female and the mean age was 39.4±9.0 (25-72); 69% were non-smokers, 21.1% were ex-smokers, and 9.9% were current smokers. Never smokers were mostly included in the group of pulmonologists younger than 40 years old (p=0.001). The number of never smokers with experience in smoking cessation outpatient clinic was higher than the number without any experience (72.1% and 67.1%, respectively; p=0.03). Smoking was 1.8-fold more likely among males (95% confidence interval-CI 1.2-2.5) and 1.8-fold more likely among those graduated before 2004 (95% CI 1.1-3.1); 66.7% of current smokers were in the contemplation stage. The number of cases in contemplation stage were mostly among regular smokers (p=0.001). Conclusion: The results of this study suggesting relatively low prevalence of smoking among pulmonologists are important for tobacco control. © 2013 by Türkiye Klinikleri.
